Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

The popular CattleFax Outlook Seminar, held as part of CattleCon 2025 in San Antonio, Texas, shared expert market and weather analysis today. The U.S. beef industry is ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

A group of scientists in China has revealed a novel mechanism whereby a short form of IL-18, generated by caspase-3 cleavage ...

With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.

Jumbo phages use a protein shield to protect their DNA from bacterial attacks. A special handshake controls which molecules ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Gain's lead program in Parkinson's disease has been awarded funding support from The Michael J. Fox Foundation for ...

Duchenne muscular dystrophy (DMD) treatment ifetroban led to improvements in measures of heart function in a Phase 2 clinical ...

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers, today announced the introduction of its Gyrolab® HEK293 HCP Type SN Kit ...

Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...